# Budesonide 9 mg Capsules in Active UC

> **NCT02550418** · PHASE2 · COMPLETED · sponsor: **Dr. Falk Pharma GmbH** · enrollment: 60 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT02550418
- **Lead sponsor:** Dr. Falk Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550418, "Budesonide 9 mg Capsules in Active UC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02550418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*